Skip to content

Comparison of Single Versus Multicenter Outcomes for Pelvic Organ Prolapse Repair Using a Mesh-capturing Device

Comparison of Single Versus Multicenter Outcomes for Pelvic Organ Prolapse Repair Using a Mesh-capturing Device

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03077490
Acronym
KIDS
Enrollment
319
Registered
2017-03-13
Start date
2015-03-04
Completion date
2017-02-01
Last updated
2019-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prolapse Genital

Keywords

Pelvic organ prolapse, transvaginal mesh, complications

Brief summary

Comparison of single versus multicenter outcomes for pelvic organ prolapse repair using a mesh-capturing device (The Uphold™ Vaginal Support System for apical and vaginal wall prolapse - Boston Scientific). 1-2 years follow up study comprison of 112 vs 207 patients.

Detailed description

112 women operated by two surgeons at one center (2 years follow up) are to be compared to 207 women operated by twenty six surgeons at twenty four centers (1 year follow-up). Screening at baseline for apical (uterine or vaginal vault) prolapse stage II with or without concomitant anterior or vaginal wall prolapse ≥ stage 2 according to the pelvic organ prolapse quantification (POP-Q) system. Surgical data including operation data, complications and hospital stay are to be compared. Anatomical outcome measurements by POP-Q evaluations. Subjective symptoms are to be evaluated by prolapse specific symptom questionnaires (PFIQ-7, UDI-6 and PFIQ) whereas sexual function to be estimated by PISQ-12.

Interventions

DEVICETransvaginal mesh Uphold TM Vaginal Support System
DEVICETransvaginal mesh Uphold TM Vaginal Support System.

Sponsors

Karolinska Institutet
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 90 Years

Inclusion criteria

Inclusion * Posthysterectomy prolapse of the vaginal apex, with or without cystocele, where the vaginal apex descends at least 50% of the total vaginal length * Uterine prolapse, with or without cystocele, where the leading edge of the cervix descends at least 50% of the total vaginal length and TVL minus point C= ≤ 2 cm * Prolapse specific pelvic symptom of pelvic heaviness and/or vaginal bulging * Reproductive years in the past (biologically or reproductive decision) * Being able to make an informed consent on participation * Physically and cognitively capable of participating in the required follow-up * No

Exclusion criteria

fulfilled

Design outcomes

Primary

MeasureTime frameDescription
The rate of immediate complicationsFrom operation start to hospital discharge, assessed for an estimated total of days (1-7 days).Serious surgical complications are categorized as any surgical event which is potentially life-threatening related to the surgical procedure including: internal organ perforation (or other injury), bleeding in excess of 1000 mL.
Rate of delayed complicationsFrom hospital discharge and up to 2 years at single center and 1 year at multicenterAdverse events during follow-up which requires re-hospitalisation or surgical re-intervention.

Secondary

MeasureTime frameDescription
Ultrasound mapping of mesh position in the pelvic floor and correlation to anatomical and subjective outcomes and sexual function5, 7, 10 yearsMesh measurements: Total mesh midsagittal length, length above and below the bladder neck (BN) level. Distance between mesh lower edge and pubis symphysis (PS) lower edge and PS level. Bladder neck: Distance between BN and PS levels. Distance between BN and PS lower edge. Urethra: Total urethra length. Distance between mid-urethra and PS lower edge and PS level. Using identical examination protocol, independent examination at rest and physical strain is to be done by senior gynecologist at an ultrasound referral unit and gynecologist. Estimation of intra class coefficient (ICC) in-between examiners in order to determine method reproducibility. To statistically compare between the collected ultrasound data and clinical outcomes. Clinical outcomes include anatomical, subjective and sexual function outcome.
Measurement of Pain by patient self-reporting Visual analogue scale (VAS-scale)Changes from baseline, 2, 5 and 10 years after surgeryVAS scale is a numeric rating scale and ranges from 0-10 (each digit is 1cm) where 0 indicates no and 10 indicates maximum, digits between 0-10 indicate degree of pain.
Anatomical outcomes2 years vs 1 yearAnatomical outcome is a composite definition including point C positioned above a point corresponding to half of the total vaginal length. The overall POP-Q outcomes will be analyzed to determine efficacy of the procedure related to correction of anterior prolapse ≥stage II or other defects present at the time of surgery. Days in hospital are counted from the day of surgery i.e. the day of operation is day 1 and the day of returning home is the last day of hospital stay.
Measurement of patient satisfaction by patient self-reporting Visual analogue scale (VAS-scale)assessment at 2, 5 and 10 years after surgeryVAS scale is a numeric rating scale and ranges from 0-10 (each digit is 1cm) where 0 indicates no and 10 indicates maximum, digits between 0-10 indicate degree of satisfaction after mesh surgery. VAS scale for patient satisfaction: 0 indicates no satisfaction whereas 10 indicates maximal satisfaction.
12. Measurement of patient recommendation to other patients to undergo same surgery with vaginal mesh if they suffer apical prolapse, assessed by patient self-reporting Visual analogue scale (VAS-scale)assessment at 2, 5 and 10 years after surgeryVAS scale is a numeric rating scale and ranges from 0-10 (each digit is 1cm) where 0 indicates no and 10 indicates maximum, digits between 0-10 indicate degree of satisfaction. VAS scale for patient recommendation to other patients to undergo same surgery if they suffer apical prolapse: 0 indicates no recommendation whereas 10 indicates maximal recommendation.
Measurement of urinary incontinence by patient self-reporting Visual analogue scale (VAS-scale)Changes from baseline, 2, 5 and 10 years after surgeryVAS scale is a numeric rating scale and ranges from 0-10 (each digit is 1cm) where 0 indicates no and 10 indicates maximum, digits between 0-10 indicate degree of severity of urinary incontinence. VAS scale for urinary incontinence: 0 indicate no urinary incontinence whereas 10 indicates maximal or severe urinary incontinence.
Subjective outcomes and sexual function2 years vs 1 yearSubjective outcome is the patients' response 'no' to question 2 of the PFDI (pelvic heaviness). The composite outcome is a strictly binary categorization where any residual sense of pelvic heaviness/vaginal bulging results in the classification of the patient as a failure. It also includes the components of the main secondary outcome considered individually, any adverse events in the aftermath of surgery, as well as, patient-reported urogenital distress (UDI), quality of life (PFIQ) and sexual function (PISQ-12) as measured by the self-reported questionnaires. For secondary analyses, the ordinal grading of responses to the PFDI-20, PFIQ-7 and PISQ-12 will be used to determine rates of improvement and progression over time.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026